167 related articles for article (PubMed ID: 36380145)
1. Identification of a novel prognostic ADME-related signature associated with tumor immunity for aiding therapy in head and neck squamous cell carcinoma.
Liu Z; Tian Y; Zhang X; Wang J; Yang J
Cancer Gene Ther; 2023 May; 30(5):659-670. PubMed ID: 36380145
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of an ADME-Related Gene Signature for Survival, Treatment Outcome and Immune Cell Infiltration in Head and Neck Squamous Cell Carcinoma.
Tang X; Li R; Wu D; Wang Y; Zhao F; Lv R; Wen X
Front Immunol; 2022; 13():905635. PubMed ID: 35874705
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
4. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma.
Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H
Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376
[TBL] [Abstract][Full Text] [Related]
5. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance.
Han Y; Shi Y; Chen B; Wang J; Liu Y; Sheng S; Fu Z; Shen C; Wang X; Yin S; Li H
Front Immunol; 2022; 13():961695. PubMed ID: 36389709
[TBL] [Abstract][Full Text] [Related]
6. A Signature of N
Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
Front Immunol; 2022; 13():809872. PubMed ID: 35185897
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
8. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
9. Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis.
Qiang W; Dai Y; Xing X; Sun X
Cancer Med; 2022 Aug; 11(16):3168-3181. PubMed ID: 35301800
[TBL] [Abstract][Full Text] [Related]
10. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.
Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J
BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of immune-related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma.
Wang Z; Yuan H; Huang J; Hu D; Qin X; Sun C; Chen G; Wang B
Head Neck; 2021 Jan; 43(1):182-197. PubMed ID: 33009692
[TBL] [Abstract][Full Text] [Related]
12.
Wei Z; Shen Y; Zhou C; Cao Y; Deng H; Shen Z
Bioengineered; 2022 May; 13(5):13784-13800. PubMed ID: 35712757
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
[TBL] [Abstract][Full Text] [Related]
14. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Song D; Tian J; Han X; Li X
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
Liu J; Lu J; Li W
BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of the
Lee MK; Noh JK; Woo SR; Kong M; Lee YC; Lee JW; Ko SG; Eun YG
Cancer Genomics Proteomics; 2022; 19(5):591-605. PubMed ID: 35985688
[TBL] [Abstract][Full Text] [Related]
17. Identification of prognostic aging-related genes associated with immunosuppression and inflammation in head and neck squamous cell carcinoma.
Yang J; Jiang Q; Liu L; Peng H; Wang Y; Li S; Tang Y; Yu J; Gan R; Liu Z
Aging (Albany NY); 2020 Nov; 12(24):25778-25804. PubMed ID: 33232279
[TBL] [Abstract][Full Text] [Related]
18. Development of a prediction model for radiotherapy response among patients with head and neck squamous cell carcinoma based on the tumor immune microenvironment and hypoxia signature.
Zhu GL; Yang KB; Xu C; Feng RJ; Li WF; Ma J
Cancer Med; 2022 Dec; 11(23):4673-4687. PubMed ID: 35505641
[TBL] [Abstract][Full Text] [Related]
19. Mast cell marker gene signature in head and neck squamous cell carcinoma.
Cai Z; Tang B; Chen L; Lei W
BMC Cancer; 2022 May; 22(1):577. PubMed ID: 35610596
[TBL] [Abstract][Full Text] [Related]
20. N6-methyladenosine-associated prognostic pseudogenes contribute to predicting immunotherapy benefits and therapeutic agents in head and neck squamous cell carcinoma.
Tan L; Qin Y; Xie R; Xia T; Duan X; Peng L; You R; Liu Y; Zou X; Zhang M; Lin M; Chen M
Theranostics; 2022; 12(17):7267-7288. PubMed ID: 36438489
[No Abstract] [Full Text] [Related]
[Next] [New Search]